NCT03797469View on ClinicalTrials.gov

Nutritional Supplements and Performance During Visual Field Testing (B3 Vitamin)

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 15, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Visual Field Defect, PeripheralGlaucoma, Open-Angle
Interventions
DIETARY_SUPPLEMENT

Vitamin B3

3 tablets of 1000 mg each will be administered orally.

DIETARY_SUPPLEMENT

Pyruvate

2 tablets of 1500 mg each will be administered orally.

DIETARY_SUPPLEMENT

Placebo

Tablets will look identical to the supplements and the number of tablets will equal the amount of supplements provided.

Trial Locations (1)

10032

Columbia University Medical Center, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT03797469 - Nutritional Supplements and Performance During Visual Field Testing (B3 Vitamin) | Biotech Hunter | Biotech Hunter